![Palatin Technologies, Inc. logo](/logos/PTN.webp)
Palatin Technologies, Inc.
AMEX:PTN
Overview | Financials
Company Name | Palatin Technologies, Inc. |
Symbol | PTN |
Currency | USD |
Price | 1.96 |
Market Cap | 26,018,216 |
Dividend Yield | 0% |
52-week-range | 1.43 - 5 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Carl Spana Ph.D. |
Website | https://palatin.com |
An error occurred while fetching data.
About Palatin Technologies, Inc.
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD